60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
The aggregate gross proceeds to the Company from the offering are expected to be $1.075 million, before deducting the placement agent fees and other offering expenses payable by the Company. The ...
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
The aggregate gross proceeds to the Company from the offering were approximately $1.075 million, before deducting the placement agent fees and other offering expenses payable by the Company. The total ...
Yahoo Finance5d
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., February 03, 2025--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S ...
Morningstar5d
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application ...
The Business Journals4d
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial
It's as significant for the medical community as it is for the local business. Silver Spring’s United Therapeutics Corp. (NASDAQ: UTHR) has scored a regulatory green light to start clinical ...
Nasdaq5d
United Therapeutics Says FDA Clears IND For The UKidney Xenotransplantation Clinical Trial
(RTTNews) - United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application ...
Investing5d
FDA approves United Therapeutics' xeno-organ trial
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. - United Therapeutics (NASDAQ:UTHR) Corporation (NASDAQ: UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a ...
STAT5d
FDA approves first xenotransplantation clinical trial, as United Therapeutics forges ahead
United Therapeutics said Monday that the Food and Drug Administration has cleared it to begin the first clinical trial testing whether organs from gene-edited pigs could provide a viable option ...
Investing5d
FDA approves United Therapeutics' xeno-organ trial
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. - United Therapeutics (NASDAQ:UTHR) Corporation (NASDAQ: UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a ...
Morningstar4d
Akari Therapeutics Joins Webull Corporate Connect Service Platform
Patel, M.D., President and Chief Executive Officer of Akari Therapeutics. To stay up to date on Akari’s recent developments on the Webull Corporate Connect Services Platform, current Webull ...